GGrantIndex
← Leaderboards

Catherine C Hedrick

Augusta University

$30,726,545
Attributed
$33,051,298
Total exposure
22
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$72,850,682 · 24

By mechanism

P01$51,455,467 · 13
R01$19,983,253 · 8
U01$1,364,962 · 1
R13$47,000 · 2

Top collaborators

Most similar at Augusta University

Same institution · by research overlap

Others in their field

Top investigators on “Atherosclerosis

Research focus

AtherosclerosisCellsMacrophageImmuneMonocytePhenotypePlayInflammatoryCholesterolCardiovascular DiseasesLinkReportingAtherogenesisSignal TransductionIn VivoLymphocyteRegulationLipidsMouse ModelProteinsBlood VesselsInflammationCell PhysiologyPrevent

Grant awards (107)

Immune Cell Interactions in Atherosclerosis$2,358,435
P01 · FY2025 · HL · contact PI
Neutrophil Development During Inflammation and Atherosclerosis$702,861
P01 · FY2025 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,311,266
P01 · FY2024 · HL · contact PI
Neutrophil Development During Inflammation and Atherosclerosis$695,031
P01 · FY2024 · HL · contact PI
2024 Immunometabolism in Health and Disease Gordon Research Conference and Gordon Research Seminar$17,000
R13 · FY2024 · AI
Immune Cell Interactions in Atherosclerosis$2,358,435
P01 · FY2023 · HL · contact PI
Neutrophil Development During Inflammation and Atherosclerosis$701,094
P01 · FY2023 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,358,435
P01 · FY2022 · HL · contact PI
Neutrophil Development During Inflammation and Atherosclerosis$702,751
P01 · FY2022 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$289,741
P01 · FY2022 · HL · contact PI
Project 1: Regulation of CD9+ Monocyte & Macrophage Immune Functions in Atherosclerosis$43,336
P01 · FY2022 · HL · contact PI
Core A: Admin Core$10,363
P01 · FY2022 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,577,670
P01 · FY2021 · HL · contact PI
Neutrophil Development During Inflammation and Atherosclerosis$717,387
P01 · FY2021 · HL · contact PI
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis$396,832
P01 · FY2021 · HL · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$136,148
U01 · FY2021 · CA · contact PI
Core A: Administrative Core$97,005
P01 · FY2021 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,577,670
P01 · FY2020 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$523,914
P01 · FY2020 · HL · contact PI
Functions of Nonclassical Monocytes in the Vasculature$450,481
R01 · FY2020 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$448,200
U01 · FY2020 · CA · contact PI
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis$396,340
P01 · FY2020 · HL · contact PI
Core A: Administrative Core$96,884
P01 · FY2020 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,577,670
P01 · FY2019 · HL · contact PI
Transcriptional Control of Monocyte Development$628,283
R01 · FY2019 · HL · contact PI
Functions of Nonclassical Monocytes in the Vasculature$436,966
R01 · FY2019 · CA · contact PI
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis$396,340
P01 · FY2019 · HL · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$362,294
U01 · FY2019 · CA · contact PI
Core A: Administrative Core$96,884
P01 · FY2019 · HL · contact PI
2019 Atherosclerosis Gordon Research Conference and Gordon Research Seminar$30,000
R13 · FY2019 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,577,497
P01 · FY2018 · HL · contact PI
Transcriptional Control of Monocyte Development$628,283
R01 · FY2018 · HL · contact PI
Functions of Nonclassical Monocytes in the Vasculature$450,481
R01 · FY2018 · CA · contact PI
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers$418,320
U01 · FY2018 · CA · contact PI
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis$396,333
P01 · FY2018 · HL · contact PI
Core A: Administrative Core$96,883
P01 · FY2018 · HL · contact PI
Immune Cell Interactions in Atherosclerosis$2,675,593
P01 · FY2017 · HL · contact PI
Transcriptional Control of Monocyte Development$628,283
R01 · FY2017 · HL · contact PI
Functions of Nonclassical Monocytes in the Vasculature$450,481
R01 · FY2017 · CA · contact PI
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis$413,218
P01 · FY2017 · HL · contact PI
Core A: Administrative Core$101,010
P01 · FY2017 · HL · contact PI
Immune Cells in Atherosclerosis and Vascular Disease$1,945,855
P01 · FY2016 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$692,467
R01 · FY2016 · HL · contact PI
Transcriptional Control of Monocyte Development$628,283
R01 · FY2016 · HL · contact PI
Lymphocytes, Cholesterol, and Atherosclerosis$554,128
P01 · FY2016 · HL · contact PI
Nuclear Receptors in Myeloid Development, Inflammation, and Atherosclerosis$553,128
R01 · FY2016 · HL · contact PI
Functions of Nonclassical Monocytes in the Vasculature$450,481
R01 · FY2016 · CA · contact PI
Administrative$133,503
P01 · FY2016 · HL · contact PI
Immune Cells in Atherosclerosis and Vascular Disease$1,920,669
P01 · FY2015 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$697,733
R01 · FY2015 · HL · contact PI
Lymphocytes, Cholesterol, and Atherosclerosis$545,812
P01 · FY2015 · HL · contact PI
Nuclear Receptors in Myeloid Development, Inflammation, and Atherosclerosis$544,830
R01 · FY2015 · HL · contact PI
Lipid Homeostasis, Immunity and Atherosclerosis$447,682
R01 · FY2015 · HL · contact PI
Administrative$131,767
P01 · FY2015 · HL · contact PI
Immune Cells in Atherosclerosis and Vascular Disease$1,914,297
P01 · FY2014 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$685,489
R01 · FY2014 · HL · contact PI
Lymphocytes, Cholesterol, and Atherosclerosis$543,044
P01 · FY2014 · HL · contact PI
Nuclear Receptors in Myeloid Development, Inflammation, and Atherosclerosis$542,065
R01 · FY2014 · HL · contact PI
Lipid Homeostasis, Immunity and Atherosclerosis$445,410
R01 · FY2014 · HL · contact PI
Administrative$131,254
P01 · FY2014 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$29,441
R01 · FY2014 · HL · contact PI
Immune Cells in Atherosclerosis and Vascular Disease$1,861,476
P01 · FY2013 · HL · contact PI
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis$707,427
R01 · FY2013 · HL · contact PI
Nuclear Receptors in Myeloid Development, Inflammation, and Atherosclerosis$545,827
R01 · FY2013 · HL · contact PI
Lymphocytes, Cholesterol, and Atherosclerosis$527,527
P01 · FY2013 · HL · contact PI
Lipid Homeostasis, Immunity and Atherosclerosis$432,684
R01 · FY2013 · HL · contact PI
Administrative$127,099
P01 · FY2013 · HL · contact PI
Immune Cells in Atherosclerosis and Vascular Disease$2,006,008
P01 · FY2012 · HL · contact PI
ABCG1 Function in Diabetes$617,191
R01 · FY2012 · HL · contact PI
Lymphocytes, Cholesterol, and Atherosclerosis$544,733
P01 · FY2012 · HL · contact PI
Lipid Homeostasis, Immunity and Atherosclerosis$454,500
R01 · FY2012 · HL · contact PI
Administrative$130,671
P01 · FY2012 · HL · contact PI
ABCG1 Function in Diabetes$617,191
R01 · FY2011 · HL · contact PI
G2A Receptor in Atherosclerosis$568,225
R01 · FY2011 · HL · contact PI
Lipid Homeostasis, Immunity and Atherosclerosis$454,500
R01 · FY2011 · HL · contact PI
Glucose, Insulin in Diabetic Vascular Disease$1,678,878
P01 · FY2010 · HL · contact PI
ABCG1 Function in Diabetes$623,425
R01 · FY2010 · HL · contact PI
G2A Receptor in Atherosclerosis$564,251
R01 · FY2010 · HL · contact PI
ABCG1 AND FOAM CELLS IN DIABETES$252,813
P01 · FY2010 · HL · contact PI
Glucose, Insulin in Diabetic Vascular Disease$1,821,531
P01 · FY2009 · HL · contact PI
ABCG1 Function in Diabetes$505,705
R01 · FY2009 · HL · contact PI
G2A Receptor in Atherosclerosis$451,586
R01 · FY2009 · HL · contact PI
ABCG1 AND FOAM CELLS IN DIABETES$273,409
P01 · FY2009 · HL · contact PI
Glucose, Insulin in Diabetic Vascular Disease$1,738,004
P01 · FY2008 · HL · contact PI
ABCG1 Function in Diabetes$496,651
R01 · FY2008 · HL · contact PI
G2A Receptor in Atherosclerosis$451,311
R01 · FY2008 · HL · contact PI
ABCG1 AND FOAM CELLS IN DIABETES$260,134
P01 · FY2008 · HL · contact PI
Core--Mouse Genetics$222,346
P01 · FY2008 · HL · contact PI
Glucose, Insulin in Diabetic Vascular Disease$1,726,340
P01 · FY2007 · HL · contact PI
Sphingolipids & Cardiovascular Disease Type l Diabetes$391,203
R01 · FY2007 · HL · contact PI
ABCG1 AND FOAM CELLS IN DIABETES$311,560
P01 · FY2007 · HL · contact PI
Core--Mouse Genetics$220,273
P01 · FY2007 · HL · contact PI
Sphingolipids & Cardiovascular Disease Type l Diabetes$390,295
R01 · FY2006 · HL · contact PI
12/15 Lipoxygenase & Monocyte: Endothelial Intractions$371,070
R01 · FY2006 · HL · contact PI
ABCG1 AND FOAM CELLS IN DIABETES$257,679
P01 · FY2006 · HL · contact PI
Core--Mouse Genetics$145,004
P01 · FY2006 · HL · contact PI
Sphingolipids &Cardiovascular Disease Type l Diabetes$422,441
R01 · FY2005 · HL
12/15 Lipoxygenase &Monocyte: Endothelial Intractions$380,000
R01 · FY2005 · HL
Core--Mouse Genetics$140,782
P01 · FY2005 · HL
Sphingolipids &Cardiovascular Disease Type l Diabetes$387,503
R01 · FY2004 · HL
12/15 Lipoxygenase &Monocyte: Endothelial Intractions$380,000
R01 · FY2004 · HL
Core--Mouse Genetics$141,993
P01 · FY2004 · HL
12/15 Lipoxygenase &Monocyte: Endothelial Intractions$380,000
R01 · FY2003 · HL
Molecular regulation of monocyte: Endothelial interactions in diabetes$0
P01 · FY2002 · HL
Core--Mouse and histology$0
P01 · FY2002 · HL
Core--Mouse and histology$0
P01 · FY2001 · HL
Molecular regulation of monocyte: Endothelial interactions in diabetes$0
P01 · FY2001 · HL